Prognostic value of dynamic contrast-enhanced MRI and plasma angiogenic markers for survival outcomes in HPV-negative oropharyngeal carcinoma treated with concurrent chemoradiotherapy

Alja Longo, Primož Strojan, Petra Hudler, Gaber Plavc, Lan Umek, Katarina Šurlan Popović

Open source

DOI
10.1007/s00234-026-04244-w
Published
2026-11-03
Container
Neuroradiology
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s00234-026-04244-w,
  title = {Prognostic value of dynamic contrast-enhanced MRI and plasma angiogenic markers for survival outcomes in HPV-negative oropharyngeal carcinoma treated with concurrent chemoradiotherapy},
  author = {Alja Longo and Primož Strojan and Petra Hudler and Gaber Plavc and Lan Umek and Katarina Šurlan Popović},
  year = {2026},
  journal = {Neuroradiology},
  doi = {10.1007/s00234-026-04244-w},
  url = {https://doi.org/10.1007/s00234-026-04244-w}
}

RIS

TY  - JOUR
TI  - Prognostic value of dynamic contrast-enhanced MRI and plasma angiogenic markers for survival outcomes in HPV-negative oropharyngeal carcinoma treated with concurrent chemoradiotherapy
AU  - Alja Longo
AU  - Primož Strojan
AU  - Petra Hudler
AU  - Gaber Plavc
AU  - Lan Umek
AU  - Katarina Šurlan Popović
PY  - 2026
JO  - Neuroradiology
DO  - 10.1007/s00234-026-04244-w
UR  - https://doi.org/10.1007/s00234-026-04244-w
ER  - 

APA

Longo, A., Strojan, P., Hudler, P., Plavc, G., Umek, L., & Popović, K. Š. (2026). Prognostic value of dynamic contrast-enhanced MRI and plasma angiogenic markers for survival outcomes in HPV-negative oropharyngeal carcinoma treated with concurrent chemoradiotherapy. Neuroradiology. https://doi.org/10.1007/s00234-026-04244-w

Source records